Small Trial Results: Hydroxychloroquine Effective For COVID-19 Treatment

Small Trial Results: Hydroxychloroquine Effective For COVID-19 Treatment


1
404
https://www.veteranstoday.com/wp-content/uploads/COVID-19_001-320x140.jpg 320w, https://www.veteranstoday.com/wp-content/uploads/COVID-19_001-640x2... 640w, https://www.veteranstoday.com/wp-content/uploads/COVID-19_001-768x3... 768w" sizes="(max-width: 1000px) 100vw, 1000px" alt="" title="COVID-19_001" />

HCQ Effective for COVID-19 in Small Randomized Trial

by Molly Walker, Associate Editor, MedPage Today

Hospitalized patients in China with COVID-19 coronavirus treated with hydroxychloroquine (HCQ), an antimalarial also used to treat autoimmune diseases, had a shorter time to clinical recovery, as well as improved pneumonia, a randomized trial found.

Patients randomized to receive hydroxychloroquine with standard treatment had a significantly shorter time to body temperature recovery of about a day, as well as a significantly reduced time to cough remission of about a day versus patients receiving only standard treatment, reported Zhan Zhang, MD, of Wuhan University in China, and colleagues.

Moreover, a larger proportion of patients in the HCQ group had improved pneumonia compared with patients in the control group (80.6% vs 54.8%), they wrote in a manuscript posted on the medRxiv preprint server.

HCQ and chloroquine for COVID-19 treatment have been in the spotlight ever since President Trump first touted their benefits in a press briefing 2 weeks ago. The FDA said it was looking into conducting randomized trials of the drug in COVID-19 patients, though some hospitals have already opted for off-label use of these agents.

One person in Arizona died after ingesting chloroquine phosphate, also sold for cleaning fish tanks, prompting the CDC to issue a warning against this practice.

Previous trials had explored in vivo activity of the drug, and one pilot study found no benefit in clinical measures or viral clearance compared with standard of care.

Still, the drug continues to be tested in ad hoc trials, including this one by Zhang and colleagues. They randomized 62 patients hospitalized with laboratory-confirmed COVID-19 infection in February. All patients received standard treatment, including oxygen therapy, antiviral agents, antibacterial agents, and immunoglobulin, with or without corticosteroids; patients in the intervention group also received oral HCQ sulfate tablets 400 mg/day on days 1-5.

Primary endpoint was time to clinical recovery, defined as “return to body temperature and cough relief, maintained for more than 72 [hours].” Mean patient age was about 45 and almost half were men, with no significant differences in the age and sex distribution between groups, the authors said.

Patients in the HCQ group had a significantly shorter time to body temperature recovery versus controls (2.2 days vs 3.2 days, P=0.0008). Similar results were seen for time to cough remission for the HCQ and control groups (2.0 vs 3.1 days, P=0.0016).

They noted four of 62 patients progressed to severe illness, all in the control group.

Two patients reported mild adverse reactions in the HCQ group, one with a rash and one with a headache.

Retinopathy is a known side effect of long-term therapy with HCQ — often seen in lupus patients who may stay on the drug for years — and patients occasionally experience arrhythmias and, more rarely, gastrointestinal reactions, cramps, and liver dysfunction. Patients should be monitored for these, but “short-term application of HCQ is relatively safe,” Zhang and colleagues wrote.

While acknowledging a need for large-scale clinical trials and other research to clarify the specific treatment mechanism and optimize the treatment plan, the authors concluded that “considering that there is no better option at present, it is a promising practice to apply HCQ to COVID-19 under reasonable management.”

Disclosures

This study was supported by the Epidemiological Study of COVID-19 Pneumonia to Science and Technology, Department of Hubei Province.

Zhang and co-authors disclosed no relevant relationships with industry.

Views: 11

Comment

You need to be a member of 12160 Social Network to add comments!

Join 12160 Social Network

Comment by stormtruther on April 2, 2020 at 6:59am

Scientists, however, warn about raising false hopes and say major studies are needed to prove the drugs are safe and effective against coronavirus

https://au.news.yahoo.com/the-controversial-drug-approved-to-fight-...

lamestream are against it ...everything they say is bullshit....therefore it probably works, deductive reasoning Dr Watson

Comment by stormtruther on April 2, 2020 at 6:52am

#9 Wormwood

Artemisinins are derived from extracts of sweet wormwood (Artemisia annua) and are well established for the treatment of malaria, including highly drug-resistant strains.

Artemisinins reduce replication rates of a host of different viruses. Artesunate is effective at stopping viral replication in 100mg per day oral doses (R).

https://men-elite.com/2020/03/13/coronavirus-the-truth-about-the-vi...

Drink Absinth and be merry, I just happen to have one in the yard because i like the buzz....two for the price of one

"Destroying the New World Order"

TOP CONTENT THIS WEEK

THANK YOU FOR SUPPORTING THE SITE!

mobile page

12160.info/m

12160 Administrators

 

Latest Activity

Doc Vega posted a blog post

The Unnerving Frequency of Disappearances on the Appalachian Trail Pt. 1

There’s another one of the cluster zones of missing persons reports that fails to render the…See More
3 hours ago
cheeki kea commented on cheeki kea's photo
Thumbnail

Waste runs deep

"Make USAID - go away."
14 hours ago
cheeki kea posted a photo
16 hours ago
cheeki kea commented on cheeki kea's photo
Thumbnail

$ Paid Annual Leave $

"Now is the Time for American Workers to Unite! Take back the squandered taxes and demand time off…"
Monday
cheeki kea posted a photo
Monday
Burbia commented on Burbia's blog post Mystery illness strikes Russia with fever, blood symptoms, and no cure in sight.
Monday
Burbia posted a blog post

Mystery illness strikes Russia with fever, blood symptoms, and no cure in sight.

I guess releasing this bio-weapon upon Israeli neighbors would be hitting too close to home. I…See More
Monday
tjdavis posted videos
Monday
tjdavis posted a video

The Electric State | Final Trailer | Netflix

Together, robots & humans can take the whole system down. THE ELECTRIC STATE starring Millie Bobby Brown, Chris Pratt and directed by the Russo Brothers, onl...
Sunday
Less Prone favorited Sandy's video
Saturday
Doc Vega's 7 blog posts were featured
Saturday
tjdavis's blog post was featured
Saturday
Sandy posted a video

"Mommy Tells Me I'm a Girl"-Jeff Younger

Soft White Underbelly interview and portrait of Jeff Younger, a father who is fighting to protect his son from transitioning into a girl. Get 40% off access ...
Saturday
tjdavis posted a video

MindWar: Full Spectrum Cognitive Dominance [Michael Aquino Analysis]

This is my analysis and my thoughts on Michael Aquino's "MindWar". This document is a must-read if you are looking to understand the psyop tactics and cognit...
Saturday
Doc Vega posted a blog post

A Horrid Murder at Land Between the Lakes (Sasquatch?)

 Most of us hear that Sasquatch-Bigfoot are intelligent yet reclusive creatures that are closely…See More
Friday
Doc Vega posted blog posts
Mar 27
cheeki kea commented on cheeki kea's video
Thumbnail

Metropolis (1927) Full Movie | 4K Color Remastered: 2023 Colorized with Gottfried Huppertz Score

"Hey thanks for the thumbs up guys. I was blown away (like a leaf in a tornado) when I watched this…"
Mar 27
tjdavis favorited cheeki kea's video
Mar 27
tjdavis posted a video

Did you know this? I was SHOCKED!

Wounder how many people know what they do to baby chicks? Wounder if they know what the are doing to Salmon? What about the lettuce and tomatoes? This will n...
Mar 27
cheeki kea posted a photo
Mar 27

© 2025   Created by truth.   Powered by

Badges  |  Report an Issue  |  Terms of Service

content and site copyright 12160.info 2007-2019 - all rights reserved. unless otherwise noted